Loading...
Chemical structure of Ralimetinib

GB40267

Ralimetinib

Also listed as LY 2228820 - Ralimetinib

Potent p38 MAPK inhibitor (IC50: 7 and 3 nM for p38α and p38β MAPKs respectively); antitumor agent for the treatment of multiple myeloma (MM) patients by reducing skeletal events and enhancing cytotoxicity of bortezomib

ChemicalCAS862505-00-8MW420.53FormulaC24H29FN6
CAS number
862505-00-8
Molecular weight
420.53
Formula
C24H29FN6
InChIKey
XPPBBJCBDOEXDN-UHFFFAOYSA-N
Catalogue number
GB40267
Brand
GLPBIO
Computed properties PubChem CID 11539025 · XLogP 5.3 · TPSA 85.4 Ų · H-bond donors 2
XLogP
5.3
TPSA
85.4 Ų
H-bond donors
2
H-bond acceptors
5
Rotatable bonds
5
Heavy atoms
31

SMILES CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N

Computed descriptors from PubChem (CID 11539025), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.